Latest dialysis Stories
The Firm is actively filing NaturaLyte and GranuFlo lawsuits on behalf of dialysis patients who allegedly suffered strokes, heart attacks and other cardiovascular problems after being administered
Analysis Shows Study Met Primary and All Secondary Endpoints THOUSAND OAKS, Calif., July 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that a Phase 3 study evaluating
NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc.
Hospital successfully transplants the first liver dialysis patient in the state HOUSTON, July 11, 2014 /PRNewswire-USNewswire/ -- Texas Children's Hospital is excited to announce the
Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/
STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical
World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney
The Firm is representing numerous GranuFlo lawsuit clients who allegedly suffered catastrophic heart events due to the use of GranuFlo or NaturaLyte dialysis concentrates. New
Special Guest Recording Artist and Former NxStage System One patient, David RUSH LAWRENCE, Mass., July 8, 2014 /PRNewswire/ -- WHAT: NxStage Kidney Care will be hosting
Fresenius Medical Care North America Recalls 56 Lots of Liquid Bicarbonate Concentrate DALLAS (PRWEB) July 04, 2014 Fresenius Medical Care North America,
- A person in a secondary role, specifically the second most important character (after the protagonist).